Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476513 · ClinicalTrials.gov registry record
Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 18
- Enrollment target
NCT02476513 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 18 participants.
The verdict
NCT02476513 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
In this study,the investigators will evaluate participants that have clinical features associated with an increased risk of esophageal disorders.The investigators will also see if there is a positive association of esophageal disorders in men,40-60 with or without abdominal obesity in the diagnosis of the following diseases; Gastroesophageal reflux disease, Barrett Esophagus and Esophageal Adenocarcinoma. The investigators hypothesize that most obese patients referred for Esophagogastroduodenoscopy will exhibit esophageal disorders. Since currently the rates of obesity and adenocarcinoma of the esophagus have increased significantly over the past 15 years, the investigators hope to find biochemical markers (i.e. pro-inflammatory mediators) in the esophagus. The investigators hope these samples will lead us to a differential expression of molecular markers and inflammatory mediators in the varying degrees of esophageal disorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02476513
The ClinicalTrials.gov registry entry for NCT02476513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02476513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02476513 about?
NCT02476513 is a clinical study titled "Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders". In this study,the investigators will evaluate participants that have clinical features associated with an increased risk of esophageal disorders.The investigators will also see if there is a positive association of esophageal disorders in men,40-60 with or without abdominal obesity in the diagnosis ...
What is the current status of trial NCT02476513?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2014-02. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT02476513?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.